• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于苯海拉明注射在吉尔吉斯监狱中的定性研究及其对减少伤害的影响。

A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.

机构信息

Yale School of Medicine, AIDS Program, 135 College Street, Suite 323, New Haven, CT, 06510, USA.

Population Health Nursing Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA.

出版信息

Harm Reduct J. 2020 Oct 31;17(1):86. doi: 10.1186/s12954-020-00435-7.

DOI:10.1186/s12954-020-00435-7
PMID:33129341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7603760/
Abstract

BACKGROUND

To reduce opioid dependence and HIV transmission, Kyrgyzstan has introduced methadone maintenance therapy and needle/syringe programs into prisons. Illicit injection of diphenhydramine, an antihistamine branded as Dimedrol, has been anecdotally reported as a potential challenge to harm reduction efforts in prisons but has not been studied systematically.

METHODS

We conducted qualitative interviews in Kyrgyz or Russian with prisoners (n = 49), former prisoners (n = 19), and stakeholders (n = 18), including prison administrators and prisoner advocates near Bishkek, Kyrgyzstan from October 2016 to September 2018. Interviews explored social-contextual factors influencing methadone utilization in prisons. Transcripts were coded by five researchers using content analysis. Dimedrol injection emerged as an important topic, prompting a dedicated analysis.

RESULTS

After drinking methadone, some people in prison inject crushed Dimedrol tablets, a non-prescription antihistamine that is banned but obtainable in prison, to achieve a state of euphoria. From the perspectives of the study participants, Dimedrol injection was associated with devastating physical and mental health consequences, including psychosis and skin infections. Moreover, the visible wounds of Dimedrol injecting contributed to the perception of methadone as a harmful drug and supporting preference for heroin over methadone.

CONCLUSION

Dimedrol injecting is a potentially serious threat to harm reduction and HIV prevention efforts in Kyrgyzstan and elsewhere in the Eastern European and Central Asian region and requires further investigation.

摘要

背景

为了减少阿片类药物依赖和艾滋病毒传播,吉尔吉斯斯坦在监狱中引入了美沙酮维持治疗和针/注射器方案。非法注射苯海拉明(一种名为苯海拉明的抗组胺药)已被传闻为监狱内减少伤害工作的潜在挑战,但尚未进行系统研究。

方法

我们于 2016 年 10 月至 2018 年 9 月期间在吉尔吉斯斯坦比什凯克附近,使用吉尔吉斯语或俄语对囚犯(n=49)、前囚犯(n=19)和利益攸关方(n=18)进行了定性访谈,包括监狱管理人员和囚犯维权人士。访谈探讨了影响监狱中美沙酮利用的社会背景因素。研究人员使用内容分析法对转录本进行了编码。苯海拉明注射成为一个重要的话题,促使我们进行了专门的分析。

结果

一些囚犯在喝完美沙酮后会注射碾碎的苯海拉明片剂,这种非处方抗组胺药虽然在监狱中被禁止但仍可获得,以达到欣快的状态。从研究参与者的角度来看,苯海拉明注射会导致严重的身心健康后果,包括精神病和皮肤感染。此外,苯海拉明注射的可见伤口导致人们认为美沙酮是一种有害药物,并支持对海洛因的偏好而不是美沙酮。

结论

苯海拉明注射可能对吉尔吉斯斯坦及东欧和中亚地区其他地方的减少伤害和艾滋病毒预防工作构成严重威胁,需要进一步调查。

相似文献

1
A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.一项关于苯海拉明注射在吉尔吉斯监狱中的定性研究及其对减少伤害的影响。
Harm Reduct J. 2020 Oct 31;17(1):86. doi: 10.1186/s12954-020-00435-7.
2
Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.在吉尔吉斯斯坦监狱中采用美沙酮的决策考虑因素:理解背景和提供准确信息的重要性。
Int J Drug Policy. 2021 Aug;94:103209. doi: 10.1016/j.drugpo.2021.103209. Epub 2021 Apr 7.
3
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.在吉尔吉斯斯坦,将美沙酮用于监狱内,并在社区释放后与治疗相联系并保持治疗,以治疗阿片类药物使用障碍患者:国家方案评估。
Int J Drug Policy. 2022 Mar;101:103558. doi: 10.1016/j.drugpo.2021.103558. Epub 2021 Dec 13.
4
Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.吉尔吉斯斯坦监狱内的药物注射:艾滋病毒风险升高及扩大阿片类激动剂治疗的影响
Int J Prison Health. 2018 Sep 10;14(3):175-187. doi: 10.1108/IJPH-03-2017-0016.
5
Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.多层次影响美沙酮维持治疗在摩尔多瓦监狱中推广的实施因素:一项定性研究。
J Subst Abuse Treat. 2022 May;136:108660. doi: 10.1016/j.jsat.2021.108660. Epub 2021 Nov 14.
6
Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.印度尼西亚感染艾滋病毒的男性囚犯在监狱内注射毒品:一种选择极为受限的行为。
Drug Alcohol Depend. 2015 Apr 1;149:71-9. doi: 10.1016/j.drugalcdep.2015.01.018. Epub 2015 Jan 25.
7
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.完美风暴:监禁与东欧和中亚地区助长艾滋病毒、丙型肝炎病毒及结核病传播的高风险环境
Lancet. 2016 Sep 17;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. Epub 2016 Jul 14.
8
Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.印度监狱内获得减少伤害及与艾滋病病毒相关治疗服务的情况:曾被监禁的注射吸毒者的经历
Int J Prison Health. 2013;9(2):82-91. doi: 10.1108/17449201311326952.
9
Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.无摄取兴趣:吉尔吉斯斯坦监狱中美沙酮利用的混合方法分析。
PLoS One. 2022 Oct 25;17(10):e0276723. doi: 10.1371/journal.pone.0276723. eCollection 2022.
10
The Global State of Harm Reduction in Prisons.监狱中减少伤害的全球状况。
J Correct Health Care. 2019 Apr;25(2):105-120. doi: 10.1177/1078345819837909.

引用本文的文献

1
Trajectory and progress of opioid agonist therapy programs in the Kyrgyz Republic.吉尔吉斯共和国阿片类激动剂治疗项目的轨迹与进展
Glob Health Econ Sustain. 2024;2(4). doi: 10.36922/ghes.2536. Epub 2024 Sep 26.
2
Introducing methadone maintenance therapy into Ukrainian prisons: a qualitative study of criminal subculture, Russia's full-scale invasion, and contested methadone objects.将美沙酮维持治疗引入乌克兰监狱:对犯罪亚文化、俄罗斯全面入侵以及有争议的美沙酮对象的定性研究
Front Psychiatry. 2023 Nov 30;14:1227216. doi: 10.3389/fpsyt.2023.1227216. eCollection 2023.
3
Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.

本文引用的文献

1
The becoming-methadone-body: on the onto-politics of health intervention translations.美沙酮化身体:论健康干预翻译的存在政治。
Sociol Health Illn. 2019 Nov;41(8):1618-1636. doi: 10.1111/1467-9566.12978. Epub 2019 Jul 16.
2
Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.吉尔吉斯斯坦监狱内的药物注射:艾滋病毒风险升高及扩大阿片类激动剂治疗的影响
Int J Prison Health. 2018 Sep 10;14(3):175-187. doi: 10.1108/IJPH-03-2017-0016.
3
Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
无摄取兴趣:吉尔吉斯斯坦监狱中美沙酮利用的混合方法分析。
PLoS One. 2022 Oct 25;17(10):e0276723. doi: 10.1371/journal.pone.0276723. eCollection 2022.
4
Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years.吉尔吉斯斯坦扩大美沙酮维持治疗的实施机会:美沙酮剂量与两年治疗期内的治疗留存率
Drug Alcohol Depend Rep. 2022 Sep;4. doi: 10.1016/j.dadr.2022.100075. Epub 2022 Jul 19.
5
Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study.队列特征描述:吉尔吉斯斯坦交叉领域耻辱感(KISS)注射吸毒者队列研究。
Harm Reduct J. 2022 May 25;19(1):53. doi: 10.1186/s12954-022-00633-5.
6
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.在吉尔吉斯斯坦,将美沙酮用于监狱内,并在社区释放后与治疗相联系并保持治疗,以治疗阿片类药物使用障碍患者:国家方案评估。
Int J Drug Policy. 2022 Mar;101:103558. doi: 10.1016/j.drugpo.2021.103558. Epub 2021 Dec 13.
7
Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.在吉尔吉斯斯坦监狱中采用美沙酮的决策考虑因素:理解背景和提供准确信息的重要性。
Int J Drug Policy. 2021 Aug;94:103209. doi: 10.1016/j.drugpo.2021.103209. Epub 2021 Apr 7.
吉尔吉斯共和国针头和注射器项目服务的接受情况:主要障碍与促进因素
Drug Alcohol Depend. 2017 Oct 1;179:180-186. doi: 10.1016/j.drugalcdep.2017.07.002. Epub 2017 Aug 2.
4
Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine.阿片类药物维持治疗患者中的多药滥用与维持治疗药物剂量不足有关。
BMC Psychiatry. 2017 Jul 6;17(1):245. doi: 10.1186/s12888-017-1415-y.
5
Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.吉尔吉斯斯坦即将获释囚犯中艾滋病毒、丙型肝炎病毒和梅毒的交叉流行:对预防和治疗的启示。
Int J Drug Policy. 2016 Nov;37:9-20. doi: 10.1016/j.drugpo.2016.06.007. Epub 2016 Jun 11.
6
Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog.塔吉克斯坦的药物制备、注射及共享行为:在库洛布和霍罗格开展的一项定性研究
Subst Abuse Treat Prev Policy. 2016 Jun 2;11(1):21. doi: 10.1186/s13011-016-0065-2.
7
Promethazine use among chronic pain patients.慢性疼痛患者中异丙嗪的使用情况。
Drug Alcohol Depend. 2015 May 1;150:92-7. doi: 10.1016/j.drugalcdep.2015.02.023. Epub 2015 Feb 26.
8
Promethazine misuse among methadone maintenance patients and community-based injection drug users.美沙酮维持治疗患者和社区注射吸毒者中异丙嗪的滥用情况。
J Addict Med. 2013 Mar-Apr;7(2):96-101. doi: 10.1097/ADM.0b013e31827f9b43.
9
Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys.可卡因与H1抗组胺药在恒河猴中强化作用的超相加相互作用。
Pharmacol Biochem Behav. 2009 Feb;91(4):590-5. doi: 10.1016/j.pbb.2008.09.013. Epub 2008 Oct 7.
10
Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.经典组胺H1受体拮抗剂:从宏观角度对其代谢和药代动力学转归的批判性综述。
Curr Drug Metab. 2003 Apr;4(2):105-29. doi: 10.2174/1389200033489523.